Clinical trial harnesses power of natural killer cells to treat neuroblastoma

Now for the first time, scientists will combine NK cell therapy with an immunocytokine to target children with relapsed/refractory neuroblastoma including those with bulky tumors.

Read more: https://www.eurekalert.org/pub_releases/2018-11/skc-cth111418.php